-

Horizon Therapeutics Named Number One Best Workplace in Chicago

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named No. 1 on the Great Place to Work® “Best Workplaces in Chicago 2020” list in the small and medium category. The list includes 39 other top small-to-medium sized companies, as well as 40 best large workplaces in the Chicago area.

“We are proud of this top workplace award and the commitment it demonstrates, especially in the challenging environment we face today,” said Irina Konstantinovsky, executive vice president, chief human resources officer, Horizon. “Our passion for patients, their families and communities fuels every decision we make, including the decision to provide employees with support that helps our team improve lives each day.”

Horizon’s No. 1 ranking was based on employees' anonymous responses to an extensive survey about their experiences at work. Great Place to Work® reviewed the survey results of more than 27,000 employees from companies across Chicago. Horizon was also recently selected as one of the 2020 Best Workplaces in Health Care and Biopharma by Great Place to Work® and Fortune.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

About the Best Workplaces in Chicago

Great Place to Work based its ranking on a data-driven methodology applied to anonymous Trust Index™ survey responses from over 27,000 employees at Great Place to Work-Certified organizations in the Chicago Metropolitan Statistical Area. This ranking was finalized prior to the COVID-19 pandemic and does not reflect companies’ roles or responses to their people or communities in addressing the impact of the coronavirus. To learn more about Great Place to Work Certification and recognition on Best Workplaces lists, visit Greatplacetowork.com.

About Great Place to Work®

Great Place to Work® is the global authority on workplace culture. They help organizations quantify their culture and produce better business results by creating a high-trust work experience for all employees. Emprising®, their culture management platform, empowers leaders with the surveys, real-time reporting, and insights they need to make data-driven people decisions. They use their unparalleled benchmark data to recognize Great Place to Work-Certified™ companies and the Best Workplaces™ in the United States and more than 60 countries, including the 100 Best Companies to Work For® list published annually in Fortune.

To learn more, visit greatplacetowork.com, listen to the podcast Better by Great Place to Work, and read “A Great Place to Work for All.” Join the community on LinkedIn, Twitter, and Instagram.

Contacts

U.S. Media Contact:
Geoffrey Curtis
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com

Ireland Media Contact:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie

Horizon Therapeutics

NASDAQ:HZNP

Release Versions

Contacts

U.S. Media Contact:
Geoffrey Curtis
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com

Ireland Media Contact:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie

More News From Horizon Therapeutics

Rule 17(e) Announcement - Horizon Therapeutics plc

DUBLIN--(BUSINESS WIRE)--  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOMMENDED CASH OFFER for HORIZON THERAPEUTICS PLC by Pillartree Limited, a private limited company wholly owned by Amgen Inc. to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of...

Rule 17(d) Announcement – Horizon Therapeutics plc

DUBLIN--(BUSINESS WIRE)--  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION October 5, 2023 RECOMMENDED CASH OFFER for HORIZON THERAPEUTICS PLC by Pillartree Limited, a private limited company wholly owned by Amgen Inc. to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies A...

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

DUBLIN--(BUSINESS WIRE)--IRISH TAKEOVER PANEL DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR, OFFEREE OR PARTIES ACTING IN CONCERT WITH THEM IN RESPECT OF DEALINGS FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS 1. KEY INFORMATION (a) Full name of discloser: Elizabeth Crossan (b) Owner or controller of interests and short positions disclosed, if different from 1(a):   The naming of nominee or vehicle companies is insufficien...
Back to Newsroom